$YYAI
Connexa Sports Technologies Inc Stock $yyai

$yyai Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223032670 Filed on September 14, 2023

Income Statement

Concept	2023 Q2	2023	2022
Revenue	$2.290M	$9.923M	$16.83M
YoY Change	-42.75%	-41.05%	55.79%
Cost Of Revenue	$1.890M	$7.144M	$12.35M
YoY Change	-47.21%	-42.14%	60.76%
Gross Profit	$400.0K	$2.778M	$4.485M
YoY Change	-4.76%	-38.05%	43.56%
Gross Profit Margin	17.47%	28.0%	26.65%
Selling, General & Admin	$2.320M	$24.67M	$46.96M
YoY Change	-67.51%	-47.46%	621.24%
% of Gross Profit	580.0%	887.98%	1047.12%
Research & Development	$0.00	$65.16K	$855.7K
YoY Change	-100.0%	-92.38%	152.12%
% of Gross Profit	0.0%	2.35%	19.08%
Depreciation & Amortization	$20.00K	$130.0K	$410.9K
YoY Change	-50.0%	-68.36%	14949.45%
% of Gross Profit	5.0%	4.68%	9.16%
Operating Expenses	$2.320M	$24.74M	$56.41M
YoY Change	-68.31%	-56.15%	723.48%
Operating Profit	-$1.920M	-$21.96M	-$51.93M
YoY Change	-72.17%	-57.71%	1293.46%
Interest Expense	$7.300M	$780.0K	$105.3K
YoY Change	274.36%	640.4%	-100.92%
% of Operating Profit
Other Income/Expense, Net	-$950.0K	-$3.319M	$154.1K
YoY Change	-145.24%	-2254.02%	-140.92%
Pretax Income	-$6.980M	-$25.28M	-$51.77M
YoY Change	144.91%	-51.18%	178.43%
Income Tax
% Of Pretax Income
Net Earnings	-$6.980M	-$71.15M	-$51.77M
YoY Change	-2.24%	37.43%	178.43%
Net Earnings / Revenue	-304.8%	-717.07%	-307.6%
Basic Earnings Per Share		-$6.36	-$13.44
Diluted Earnings Per Share	-$20.52	-$6.36	-$13.46
COMMON SHARES
Basic Shares Outstanding	13.54M shares	11.20M shares	3.848M shares
Diluted Shares Outstanding		11.20M shares	3.848M shares

Balance Sheet

Concept	2023 Q2	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$200.0K	$200.0K	$1.420M
YoY Change	-85.92%	-85.92%	52.89%
Cash & Equivalents	$202.1K	$200.0K	$1.420M
Short-Term Investments
Other Short-Term Assets	$1.200M	$1.200M	$1.660M
YoY Change	-27.71%	-27.71%	729.34%
Inventory	$3.190M	$3.190M	$8.190M
Prepaid Expenses
Receivables	$399.7K	$400.0K	$1.560M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.992M	$4.990M	$12.83M
YoY Change	-61.08%	-61.11%	129.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.79K	$10.00K	$170.0K
YoY Change	-91.51%	-94.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$4.690M
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$2.116M	$2.120M	$62.03M
YoY Change	-96.59%	-96.58%	54866.77%
TOTAL ASSETS
Total Short-Term Assets	$4.992M	$4.990M	$12.83M
Total Long-Term Assets	$2.116M	$2.120M	$62.03M
Total Assets	$7.108M	$7.110M	$74.86M
YoY Change	-90.51%	-90.5%	1213.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.497M	$5.500M	$6.470M
YoY Change	-14.98%	-14.99%	215.54%
Accrued Expenses	$4.912M	$6.270M	$8.790M
YoY Change	-12.32%	-28.67%	332.77%
Deferred Revenue
YoY Change
Short-Term Debt	$1.480M	$1.480M	$14.97M
YoY Change	-90.11%	-90.11%	143.68%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.77M	$23.77M	$38.98M
YoY Change	-39.03%	-39.02%	61.49%
LONG-TERM LIABILITIES
Long-Term Debt	$1.950M	$1.950M	$2.000M
YoY Change	-2.5%	-2.5%	18983.97%
Other Long-Term Liabilities	$0.00	$0.00	$1.370M
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$1.954M	$1.950M	$3.370M
YoY Change	-42.03%	-42.14%	32056.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.77M	$23.77M	$38.98M
Total Long-Term Liabilities	$1.954M	$1.950M	$3.370M
Total Liabilities	$25.72M	$25.72M	$42.35M
YoY Change	-39.27%	-39.27%	75.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.8M
YoY Change	88.28%
Common Stock	$133.0M
YoY Change	17.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$18.61M	-$18.61M	$32.51M
YoY Change
Total Liabilities & Shareholders Equity	$7.108M	$7.110M	$74.86M
YoY Change	-90.51%	-90.5%	1213.91%

Cashflow Statement

Concept	2023 Q2	2023	2022
OPERATING ACTIVITIES
Net Income	-$6.980M	-$71.15M	-$51.77M
YoY Change	-2.24%	37.43%	178.43%
Depreciation, Depletion And Amortization	$20.00K	$130.0K	$410.9K
YoY Change	-50.0%	-68.36%	14949.45%
Cash From Operating Activities	$480.0K	-$6.365M	-$11.46M
YoY Change	-110.5%	-44.47%	153.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$1.618M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00		-$1.618M
YoY Change	-100.0%		5294.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$8.745M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-660.0K	$5.821M	$13.73M
YoY Change	-118.75%	-57.62%	153.4%
NET CHANGE
Cash From Operating Activities	480.0K	-$6.365M	-$11.46M
Cash From Investing Activities	0.000		-$1.618M
Cash From Financing Activities	-660.0K	$5.821M	$13.73M
Net Change In Cash	-180.0K	-$462.9K	$652.3K
YoY Change	-57.14%	-170.97%	-25.24%
FREE CASH FLOW
Cash From Operating Activities	$480.0K	-$6.365M	-$11.46M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	CNXA	Shares Issued For Contingent Consideration SharesIssuedForContingentConsideration		usd
CY2023	CNXA	Elimination Of Related Party Derivative Liabilities EliminationOfRelatedPartyDerivativeLiabilities		usd
CY2023	CNXA	Derivative Liabilities Recorded As Debt Discounts Of Convertible Notes DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes		usd
CY2022	CNXA	Derivative Liability Recorded For Shares And Warrants Issued In Private Placement DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001674440
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	us-gaap	Commodity Contract Asset Current CommodityContractAssetCurrent		usd
CY2023Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent		usd
CY2023Q2	us-gaap	Purchase Obligation PurchaseObligation		usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	CNXA	Gain Loss On Issuance Of Convertible Notes GainLossOnIssuanceOfConvertibleNotes		usd
CY2023	CNXA	Gain Loss On Change In Fair Value Of Contingent Consideration GainLossOnChangeInFairValueOfContingentConsideration		usd
CY2022	CNXA	Derivative Expense DerivativeExpense		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	CNXA	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2023	CNXA	Gain Loss On Change In Fair Value Of Contingent Consideration GainLossOnChangeInFairValueOfContingentConsideration		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	CNXA	Derivative Expense DerivativeExpense		usd
CY2023	CNXA	Gain Loss On Issuance Of Convertible Notes GainLossOnIssuanceOfConvertibleNotes		usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
CY2023	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired
CY2022Q2	CNXA	Deferred Tax Assets Accrued Payroll DeferredTaxAssetsAccruedPayroll		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount		usd
CY2022	CNXA	Income Tax Recociliation Loss On Extinguishment Of Debt IncomeTaxRecociliationLossOnExtinguishmentOfDebt		usd
CY2023	CNXA	Income Tax Recociliation Accrued Payroll IncomeTaxRecociliationAccruedPayroll		usd
CY2022	CNXA	Income Tax Recociliation Accrued Payroll IncomeTaxRecociliationAccruedPayroll		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	CNXA	Disposal Group Including Discontinued Operation Other Income Loss DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	01-41423
CY2023	dei	Entity Registrant Name EntityRegistrantName	CONNEXA SPORTS TECHNOLOGIES INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	61-1789640
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2709 NORTH ROLLING ROAD
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 138
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	WINDSOR MILL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21244
CY2023	dei	City Area Code CityAreaCode	(443)
CY2023	dei	Local Phone Number LocalPhoneNumber	407-7564
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	CNXA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	2920045.96	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24148532	shares
CY2023	dei	Auditor Firm AuditorFirmId	5968
CY2023	dei	Auditor Name AuditorName	OLAYINKA OYEBOLA & CO.
CY2023	dei	Auditor Location AuditorLocation	Lagos, Nigeria
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	202095	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	665002	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	399680	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1033390	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	3189766	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	7861837	usd
CY2023Q2	CNXA	Prepaid Inventory Current PrepaidInventoryCurrent	936939	usd
CY2022Q2	CNXA	Prepaid Inventory Current PrepaidInventoryCurrent	499353	usd
CY2022Q2	us-gaap	Commodity Contract Asset Current CommodityContractAssetCurrent	235526	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	263020	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272670	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2258318	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4991500	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	12826096	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	2000000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14791	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47355	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	101281	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4842856	usd
CY2022Q2	us-gaap	Goodwill Goodwill	6781193	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	50365446	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	2116072	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	62036850	usd
CY2023Q2	us-gaap	Assets Assets	7107572	usd
CY2022Q2	us-gaap	Assets Assets	74862946	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5496629	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5252665	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4911839	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4381901	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	500000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	111506	usd
CY2023Q2	CNXA	Notes Payable Current Excluding Convertible Notes Payable Net NotesPayableCurrentExcludingConvertibleNotesPayableNet	1484647	usd
CY2022Q2	CNXA	Notes Payable Current Excluding Convertible Notes Payable Net NotesPayableCurrentExcludingConvertibleNotesPayableNet	4639376	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	10327778	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	10489606	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5443779	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	418455	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1334000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22971	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	156862	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	5215222	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23767491	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	38980522	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1370492	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1953842	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3370492	usd
CY2023Q2	us-gaap	Liabilities Liabilities	25721333	usd
CY2022Q2	us-gaap	Liabilities Liabilities	42351014	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13543155	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13543155	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194836	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194836	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	13544	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	4195	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	132980793	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	113049700	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151750610	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80596925	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	142512	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	54962	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-18613761	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32511932	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7107572	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74862946	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9922799	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16102672	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7144335	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11878010	usd
CY2023	us-gaap	Gross Profit GrossProfit	2778464	usd
CY2022	us-gaap	Gross Profit GrossProfit	4224662	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1928198	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3477570	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22743877	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46718986	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65164	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	736141	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	24737239	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	50932697	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-21958775	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-46708035	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4095030	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8150284	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7096730	usd
CY2022	CNXA	Gain Loss On Issuance Of Convertible Notes GainLossOnIssuanceOfConvertibleNotes	-5889369	usd
CY2022	CNXA	Gain Loss On Change In Fair Value Of Contingent Consideration GainLossOnChangeInFairValueOfContingentConsideration	4847000	usd
CY2023	CNXA	Gain Loss On Change In Fair Value Of Derivatives Liability GainLossOnChangeInFairValueOfDerivativesLiability	10950017	usd
CY2022	CNXA	Gain Loss On Change In Fair Value Of Derivatives Liability GainLossOnChangeInFairValueOfDerivativesLiability	18557184	usd
CY2023	CNXA	Derivative Expense DerivativeExpense	8995962	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3319050	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	182060	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25277825	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46525975	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-4461968	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-5247677	usd
CY2023	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-41413892	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-45875860	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-5247677	usd
CY2023	CNXA	Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71153685	usd
CY2022	CNXA	Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51773652	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-71153685	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51773652	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	87550	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	75132	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-71066135	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51698520	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.26
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.26
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-12.09
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-12.09
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-4.10
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-4.10
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.36
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.36
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.36
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.36
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.46
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.46
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11195345	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11195345	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3847672	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3847672	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-18450744	usd
CY2022	CNXA	Stock Issued During Period Value Conversionof Notes Payable Related Parties StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties	6220002	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3550000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6921	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2750	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2003383	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32473602	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	8754538	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	75132	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51773652	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32511932	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32511932	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14046300	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	915545	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	37086	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4195000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	746511	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	87550	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	87550	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-71153685	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-18613761	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-71153685	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51773652	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11555332	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43534	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	10950017	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18557184	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	37086	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2010304	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	746511	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	32473602	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-41413892	usd
CY2022	CNXA	Gain Loss On Change In Fair Value Of Contingent Consideration GainLossOnChangeInFairValueOfContingentConsideration	4847000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7096730	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4095030	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8150284	usd
CY2023	CNXA	Derivative Expense DerivativeExpense	8995962	usd
CY2023	CNXA	Noncash Transaction Costs NoncashTransactionCosts	454823	usd
CY2022	CNXA	Noncash Transaction Costs NoncashTransactionCosts	2250000	usd
CY2022	CNXA	Gain Loss On Issuance Of Convertible Notes GainLossOnIssuanceOfConvertibleNotes	-5889369	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1368643	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	268930	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4413056	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4186493	usd
CY2023	CNXA	Increase Decrease In Prepaid Inventory IncreaseDecreaseInPrepaidInventory	138308	usd
CY2022	CNXA	Increase Decrease In Prepaid Inventory IncreaseDecreaseInPrepaidInventory	520580	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-430193	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	320679	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-598814	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6087601	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-53287	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-41451	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1126123	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2978265	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	158187	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1813516	usd
CY2023	CNXA	Increase Decrease In Interest Payable Related Party IncreaseDecreaseInInterestPayableRelatedParty	9201	usd
CY2022	CNXA	Increase Decrease In Interest Payable Related Party IncreaseDecreaseInInterestPayableRelatedParty	161120	usd
CY2023	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	60326327	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	34255478	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10827358	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-17518174	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	4461969	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	5151474	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6365389	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12366700	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	125659	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2250000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2124341	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	506000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1618341	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8744882	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	800251	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5500000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2000000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	11000000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	546158	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4377537	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3965463	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5821187	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13734286	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	81295	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-193	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-462907	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-250948	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	665002	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	915950	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	202095	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	665002	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	482687	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	222210	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	111105	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	3550000	usd
CY2023	CNXA	Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock	14046300	usd
CY2022	CNXA	Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock	6220003	usd
CY2023	CNXA	Shares Issued For Contingent Consideration SharesIssuedForContingentConsideration	915545	usd
CY2022	CNXA	Elimination Of Related Party Derivative Liabilities EliminationOfRelatedPartyDerivativeLiabilities	8754538	usd
CY2022	CNXA	Derivative Liabilities Recorded As Debt Discounts Of Convertible Notes DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes	10199749	usd
CY2023	CNXA	Derivative Liability Recorded For Shares And Warrants Issued In Private Placement DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement	4999882	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	2000000	usd
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	3486599	usd
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151750610	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zZphjCY6iJMd">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z4iek6XCOzT7">Financial Statement Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13543155	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13543155	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194836	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194836	shares
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	209690	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	175000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1509985	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4073791	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1712553	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2559848	usd
CY2023Q2	CNXA	Capitalized Duty And Freight CapitalizedDutyAndFreight	517228	usd
CY2022Q2	CNXA	Capitalized Duty And Freight CapitalizedDutyAndFreight	1328198	usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	550000	usd
CY2022Q2	us-gaap	Inventory Adjustments InventoryAdjustments	100000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	3189766	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	7861837	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6063145	shares
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4389469	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	1923920	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	27000	shares
CY2023Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z14jdvKg80tl">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	10489606	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	10950017	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	279739	shares
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6781193	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	6000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3882967	shares
CY2022Q2	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding	11.1125
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100951	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49983	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1905311	shares
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5780	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5780	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5780	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5780	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5780	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	72381	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	101281	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1535186	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	921759	usd
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1720606	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1014833	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	490424	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1706560	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1165623	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	738749	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4911839	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4381901	usd
CY2021Q2	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding	5.1289
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	68565047	shares
CY2023	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued	0.2924
CY2023Q2	CNXA	Remaining Derivative Liabilities RemainingDerivativeLiabilities	1862450	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	800251	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	14689369	usd
CY2021Q4	CNXA	Loss On Issuance Of Convertible Notes LossOnIssuanceOfConvertibleNotes	3689369	usd
CY2021Q4	CNXA	Securities Outstanding Rate Convertible Notes Descripition SecuritiesOutstandingRateConvertibleNotesDescripition	On December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the “Omnibus Agreement”) with certain Purchasers who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement, the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December 31, 2021 by such Purchaser (each, an “Existing Note”).
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4389469	shares
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	13200000	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	846301	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	13200000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1501914	usd
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1250004	usd
CY2022Q1	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	4000000	usd
CY2022Q1	CNXA	Number Of Consigned Goods NumberOfConsignedGoods	13000	integer
CY2023Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt	4000000	usd
CY2022Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	500000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1977656	shares
CY2022	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued	5.9836
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	750000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	71698014	shares
CY2023Q2	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding	0.8552
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3882967	shares
CY2022Q2	CNXA	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding	11.1125
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2344529	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	33752623	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P6Y5M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P6Y6M
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	71698014	shares
CY2023	us-gaap	Payments For Rent PaymentsForRent	4900	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	22176	usd
CY2023Q1	CNXA	Fair Value Of Common Stock FairValueOfCommonStock	1334000	usd
CY2022Q2	CNXA	Fair Value Of Common Stock FairValueOfCommonStock	1334000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	598396	shares
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	418455	usd
CY2023Q1	CNXA	Minimum Bid Price MinimumBidPrice	1.00
CY2023Q1	CNXA	Minimum Bid Price MinimumBidPrice	1.00
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11700000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3049000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2166000	usd
CY2023Q2	CNXA	Deferred Tax Assets Stock Options DeferredTaxAssetsStockOptions	8454000	usd
CY2022Q2	CNXA	Deferred Tax Assets Stock Options DeferredTaxAssetsStockOptions	8259000	usd
CY2023Q2	CNXA	Deferred Tax Assets Accrued Payroll DeferredTaxAssetsAccruedPayroll	11039000	usd
CY2023Q2	CNXA	Deferred Tax Assets Related Party Accruals DeferredTaxAssetsRelatedPartyAccruals	1001000	usd
CY2022Q2	CNXA	Deferred Tax Assets Related Party Accruals DeferredTaxAssetsRelatedPartyAccruals	799000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	133000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	100000	usd
CY2023Q2	CNXA	Deferred Tax Assets Interest Deferral DeferredTaxAssetsInterestDeferral	221000	usd
CY2022Q2	CNXA	Deferred Tax Assets Interest Deferral DeferredTaxAssetsInterestDeferral	191000	usd
CY2023Q2	CNXA	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	81000	usd
CY2022Q2	CNXA	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	84000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	131000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	57000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24109000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11656000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10983000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10259000	usd
CY2023	CNXA	Income Tax Reconciliation Debt Discount Amortization IncomeTaxReconciliationDebtDiscountAmortization	860000	usd
CY2022	CNXA	Income Tax Reconciliation Debt Discount Amortization IncomeTaxReconciliationDebtDiscountAmortization	1841000	usd
CY2023	CNXA	Income Tax Reconciliation Related Party Accruals IncomeTaxReconciliationRelatedPartyAccruals	226000	usd
CY2022	CNXA	Income Tax Reconciliation Related Party Accruals IncomeTaxReconciliationRelatedPartyAccruals	150000	usd
CY2023	CNXA	Income Tax Reconciliation Start Up Costs IncomeTaxReconciliationStartUpCosts	-145000	usd
CY2022	CNXA	Income Tax Reconciliation Start Up Costs IncomeTaxReconciliationStartUpCosts	6815000	usd
CY2023	CNXA	Income Tax Recociliation Interest Expense IncomeTaxRecociliationInterestExpense	79000	usd
CY2022	CNXA	Income Tax Recociliation Interest Expense IncomeTaxRecociliationInterestExpense	5000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-18000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	21000	usd
CY2023	CNXA	Income Tax Recociliation Inventory Reserve IncomeTaxRecociliationInventoryReserve	26000	usd
CY2022	CNXA	Income Tax Recociliation Inventory Reserve IncomeTaxRecociliationInventoryReserve	55000	usd
CY2023	CNXA	Income Tax Recociliation Interest Deferral IncomeTaxRecociliationInterestDeferral	-5000	usd
CY2022	CNXA	Income Tax Recociliation Interest Deferral IncomeTaxRecociliationInterestDeferral	13000	usd
CY2023	CNXA	Income Tax Recociliation Acquisition Costs IncomeTaxRecociliationAcquisitionCosts	260000	usd
CY2022	CNXA	Income Tax Recociliation Acquisition Costs IncomeTaxRecociliationAcquisitionCosts	1268000	usd
CY2023	CNXA	Income Tax Recociliation Accrued Legal IncomeTaxRecociliationAccruedLegal	-76000	usd
CY2022	CNXA	Income Tax Recociliation Accrued Legal IncomeTaxRecociliationAccruedLegal	76000	usd
CY2023	CNXA	Income Tax Recociliation Loss On Extinguishment Of Debt IncomeTaxRecociliationLossOnExtinguishmentOfDebt	8713000	usd
CY2023	CNXA	Income Tax Recociliation Gain On Change In Fair Value Of Derivatives IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives	481000	usd
CY2022	CNXA	Income Tax Recociliation Gain On Change In Fair Value Of Derivatives IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives	-1298000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	40000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-29000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	542000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1342000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1049000	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1020000	usd
CY2022Q4	us-gaap	Cash Cash	500000	usd
CY2022Q4	us-gaap	Investments Investments	500000	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	916082	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	288980	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	323307	usd
CY2022Q2	CNXA	Disposal Group Including Discontinued Operation Right Of Use Asset Operating Leases Current DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent	239689	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	490260	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2258318	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Goodwill Noncurrent DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent	25862000	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent	126862	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent	19473646	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	209363	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory Noncurrent DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent	4693575	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	50365446	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	2432818	usd
CY2022Q2	CNXA	Disposal Group Including Discontinued Operation Lease Liability Operating Leases Current DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent	237204	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	2545200	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	5215222	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Liabilities DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities	1370492	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1370492	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3954149	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	728805	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	8416117	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	5948508	usd
CY2022	CNXA	Disposal Group Including Discontinued Operation Other Income Loss DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss	27974	usd
CY2023	CNXA	Disposal Group Including Discontinued Operation Net Income Loss DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss	-4461968	usd
CY2022	CNXA	Disposal Group Including Discontinued Operation Net Income Loss DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss	-5247677	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.221

Files In Submission

Name	View Source	Status
0001493152-23-032670-index-headers.html	Edgar Link	pending
0001493152-23-032670-index.html	Edgar Link	pending
0001493152-23-032670.txt	Edgar Link	pending
0001493152-23-032670-xbrl.zip	Edgar Link	pending
cnxa-20230430.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
form10-k_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
cnxa-20230430_cal.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cnxa-20230430_def.xml	Edgar Link	unprocessable
cnxa-20230430_lab.xml	Edgar Link	unprocessable
cnxa-20230430_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YYAI
Connexa Sports Technologies Inc Stock $yyai

2023 Q2 Form 10-K Financial Statement

#000149315223032670 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YYAI Connexa Sports Technologies Inc Stock $yyai

2023 Q2 Form 10-K Financial Statement

#000149315223032670 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YYAI
Connexa Sports Technologies Inc Stock $yyai